ink or handling

Batch records with faded or illegible handwriting

Laboratory notebooks containing overwritten or unclear results

Electronic printouts that fade over time due to thermal printing

Corrective entries made without ensuring original legibility

QA reviewers approving records despite poor readability

Each of these failures compromises regulatory trust and can invalidate batch documentation.

Root Causes and Contributing Factors

Risk assessments often identify systemic causes for illegible records:

• Poor Documentation Tools: Use of low-quality pens, paper, or thermal printers.
• Environmental Factors: Humidity, dust, and chemical exposure causing ink smudging.
• Weak SOPs: Lack of clear guidance on documentation tools and practices.
• Training Gaps: Staff unaware of legibility requirements.
• QA Oversight Weaknesses: Reviewers approving records without ensuring clarity.
• Archival Issues: Poor storage leading to fading or deterioration of documents.

Unless addressed, these factors result in recurring illegibility issues across records.

How to Conduct a Risk Assessment for Illegible Records

A structured risk assessment helps quantify and address the impact of illegible records:

1. Identify Impacted Records: Determine which logbooks, batch records, or laboratory data are illegible.
2. Assess Process Impact: Evaluate whether illegibility affects critical process steps or product quality.
3. Perform Severity Assessment: Categorize impact (e.g., minor, major, or critical) based on regulatory relevance.
4. Analyze Root Cause: Identify why the record became illegible (ink, paper, handling, environment).
5. Evaluate Detectability: Determine if QA or internal audits could have detected the issue earlier.
6. Rate Risk: Use a risk matrix (severity, probability, detectability) to assign a risk score.
7. Define Mitigation: Propose corrective and preventive measures.

This systematic approach ensures risk is documented and addressed in line with ICH Q9 (Quality Risk Management).

Preventive Strategies for Documentation Legibility

To avoid illegible or smudged records, organizations should adopt best practices:

• Use indelible ink pens of approved quality
• Train staff on proper documentation practices
• Specify documentation tools in SOPs
• Prohibit pencil entries or erasable inks
• Implement electronic systems where feasible (validated eLogs, EBRs)
• Review records promptly to detect and correct legibility issues
• Ensure archival conditions prevent fading or damage
• Audit for legibility during internal inspections

Preventive measures reinforce data integrity and reduce compliance risks.

Corrective and Preventive Actions (CAPA)

When illegible or smudged records are identified, CAPA should be applied systematically:

1. Document the deviation in the QMS
2. Evaluate impact on product quality and regulatory submissions
3. Reconstruct records transparently if possible, ensuring original data is retained
4. Revise SOPs to specify approved tools and practices for documentation
5. Retrain staff on legibility and documentation expectations
6. Introduce preventive tools (e.g., electronic systems, archival printers)
7. Verify CAPA effectiveness with trending analysis and internal audits

Effective CAPA demonstrates accountability and commitment to sustaining documentation integrity.

Checklist for Internal Compliance Readiness

• All GMP records legible, complete, and reviewed promptly
• Documentation tools and practices standardized
• No use of pencil, erasable ink, or unapproved writing instruments
• QA oversight includes checks for legibility
• SOPs specify documentation quality requirements
• Archival systems protect against deterioration
• Electronic systems validated with audit trails
• Training logs confirm staff awareness of legibility requirements
• Deviations raised and CAPA applied for illegible entries
• Internal audits include focus on record clarity

This checklist helps organizations sustain compliance and prepare for inspections.

Conclusion: Sustaining Compliance Through Clear Documentation

Illegible or smudged GMP records are not minor clerical issues—they are serious data integrity violations that undermine the credibility of pharmaceutical operations. Regulators expect records to be clear, permanent, and reliable. Through structured risk assessments, strong SOPs, preventive strategies, and robust CAPA, companies can protect documentation integrity and avoid inspection findings. Sustaining compliance requires a proactive culture where clarity of records is valued as highly as accuracy and completeness.

Abbreviations

• GMP – Good Manufacturing Practice
• FDA – Food and Drug Administration
• EMA – European Medicines Agency
• WHO – World Health Organization
• PIC/S – Pharmaceutical Inspection Co-operation Scheme
• CAPA – Corrective and Preventive Action
• SOP – Standard Operating Procedure
• QMS – Quality Management System
• ALCOA+ – Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available
• EBR – Electronic Batch Record
• eLogs – Electronic Logbooks

References

• FDA 21 CFR Part 211
• EU GMP Guidelines (EudraLex Volume 4)
• WHO GMP Guidelines
• PIC/S Publications